147: Regulation of Inflammation
The licence covers work that will support the development of new drugs to regulate and treat inflammatory diseases such as rheumatoid arthritis, asthma and inflammatory bowel diseases which are caused by misdirected immune responses against self
Date: Tue Jun 06 08:21:34 BST 2006
